ClearPoint Neuro (CLPT) Earnings Analysis
ClearPoint Neuro (CLPT) has no confirmed upcoming earnings date. Last quarter (2026-03-17) it missed with EPS -0.27 USD vs -0.22 USD est (-22.7%). It has beaten estimates in 0/3 recent quarters (0%). Trailing P/E -14.88.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLPT next report earnings?
No confirmed upcoming earnings date is currently scheduled for CLPT. This page updates as the calendar is published.
CLPT earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-17 | -0.27 USD | -0.22 USD | -22.7% | Miss |
| 2025-11-06 | -0.21 USD | -0.2 USD | -5% | Miss |
| 2025-02-26 | -0.2 USD | -0.15 USD | -33.3% | Miss |
Beat rate: 0/3 (0%) over reported quarters with consensus data.
CLPT valuation and analyst view
| Trailing P/E | -14.88 |
|---|---|
| Trailing EPS | -0.98372 USD |
| Price / book | 23.57 |
| Dividend yield | 0.00% |
| Market cap | 0.45B |
| Analyst consensus | Buy (3 buy / 0 hold / 0 sell) |
| Avg price target | 16 USD |
Related research pages
Frequently asked questions
When is ClearPoint Neuro (CLPT)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for CLPT. This page updates as the calendar is published.
Did CLPT beat earnings last quarter?
In its 2026-03-17 report, CLPT posted EPS of -0.27 USD versus a -0.22 USD estimate — a miss of 22.7%.
What is CLPT's earnings track record?
Over the last 3 reported quarters with consensus data, CLPT beat estimates 0 times (0%).
What is CLPT's current P/E ratio and EPS?
CLPT trades at a trailing P/E of -14.88 on trailing EPS of -0.9837245471088344 USD.
What do analysts rate CLPT?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 16 USD.